GT Biopharma

(NASDAQ) GTBP

Current Price$0.44

Market Cap$15.74M

Since IPO (1983)-100%

5 Year-100%

1 Year-84%

1 Month+8%

GT Biopharma Financials at a Glance

Market Cap

$15.74M

Revenue (TTM)

$0.00

Net Income (TTM)

-$47.73M

EPS (TTM)

-$14.40

P/E Ratio

-0.03

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$0.44

Volume

1,330,487.027

Open

$0.47

Price

$0.44

Volume

1,330,487.027

Open

$0.47

Previous Close

$0.44

Daily Range

$0.43 - $0.47

52-Week Range

$0.26 - $3.85

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.02 (Average)

Price

$0.44

Volume

1,330,487.027

Open

$0.47

Previous Close

$0.44

Daily Range

$0.43 - $0.47

52-Week Range

$0.26 - $3.85

Estimated Earnings Date

Aug 12, 2026

GTBP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GT Biopharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Michael Breen

Website

www.gtbiopharma.com

Headquarters

San Francisco, CA 94005, US

GTBP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-1446%

Return on Capital

-2%

Return on Assets

-5%

Earnings Yield

-33.33%

Dividend Yield

0.00%

Payout Ratio

-0.48%

Stock Overview

Market Cap

$15.74M

Shares Outstanding

36.06M

Volume

1.33M

Avg. Volume

1.23M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$12.42M

EBITDA

-$12.42M

Operating Cash Flow

-$12.91M

Capital Expenditure

$0.00

Free Cash Flow

-$12.91M

Cash & ST Invst.

$6.81M

Total Debt

$0.00

GT Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$15.74M

N/A

Market Cap/Employee

$15.74M

N/A

Employees

N/A

Net Income

-$2.83M

-265.1%

EBITDA

-$2.85M

-47.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$8.92M

+277.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-4.78%

N/A

Return on Invested Capital

-1.76%

N/A

Free Cash Flow

-$2.47M

-12.1%

Operating Cash Flow

-$2.47M

-12.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

REVBRevelation Biosciences, Inc.

REVBRevelation Biosciences, Inc.$0.99-6.16%

ARTLArtelo Biosciences, Inc.

ARTLArtelo Biosciences, Inc.$1.38-3.50%

SLXNSilexion Therapeutics Ltd.

SLXNSilexion Therapeutics Ltd.$4.67-5.85%

PTIXProtagenic Therapeutics, Inc.

PTIXProtagenic Therapeutics, Inc.$0.50-5.66%

DRMADermata Therapeutics, Inc.

DRMADermata Therapeutics, Inc.$1.18-5.60%

LIPOLipella Pharmaceuticals Inc.

LIPOLipella Pharmaceuticals Inc.$0.11+31.25%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.05-0.14%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.13-0.13%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.19+0.14%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$34.14-0.05%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.50+0.02%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$11.87-0.11%

SOFISoFi Technologies

SOFISoFi Technologies$16.03-0.07%

Questions About GTBP

What is the current price of GT Biopharma?

GT Biopharma is trading at $0.44 per share.

What is the 52-week range for GT Biopharma?

Over the past 52 weeks, GT Biopharma has traded between $0.26 and $3.85.

How much debt does GT Biopharma have?

As of the most recent reporting period, GT Biopharma reported total debt of $0.00.

How much cash does GT Biopharma have on hand?

GT Biopharma reported $9.02M in cash and cash equivalents in its most recent financial results.

What is GT Biopharma’s dividend yield?

GT Biopharma does not currently have a dividend yield.

GT Biopharma

GT Biopharma Financials at a Glance

GTBP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About GT Biopharma

GTBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

GT Biopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GTBP

What is the current price of GT Biopharma?

What is the 52-week range for GT Biopharma?

How much debt does GT Biopharma have?

How much cash does GT Biopharma have on hand?

What is GT Biopharma’s dividend yield?

Premium Investing Services